Data Vantage: iPid, Aevice Health, Aprisium, Nurasa and BillEase in focus

Data Vantage: iPid, Aevice Health, Aprisium, Nurasa and BillEase in focus

This web version of the DATA VANTAGE twice-weekly premium newsletter is available only to our premium subscribers. Unlock access by picking up any of our premium subscription plans.

Singapore-based fintech startup iPiD (International Payments Identity) issued shares worth $8.25 million to several investors last week, according to regulatory filings.

Edited by: Deepshikha Monga